Core Viewpoint - Hai Xi Pharmaceutical (02637.HK) has announced that it will list on the Hong Kong Stock Exchange on October 20, 2025, instead of the previously scheduled date of October 17, 2025 [3]. Summary by Relevant Sections Company Information - Stock Code: 2637 - Stock Abbreviation: Hai Xi Pharmaceutical - Listing Date: October 20, 2025 [4]. Pricing Information - Final Offer Price: HKD 86.40 - Offer Price Range: HKD 69.88 to HKD 86.40 - No adjustments made to the offer price [4]. Share Offering and Capital Structure - Total number of shares offered: 11,500,000 - Number of shares for public offering (after adjustments): 1,150,000 - Number of shares for international offering (after adjustments): 10,350,000 - Total number of shares issued at listing: 78,707,270 [4]. Over-allotment and Proceeds - Number of over-allotted shares: 0 - Total proceeds (before expenses): HKD 993.60 million - Estimated listing expenses (based on final offer price): HKD 53.47 million - Net proceeds: HKD 940.13 million [4].
福建海西新药(02637)，将于下周一(10月20日)香港上市